Support Apnea Board & OSCAR  

Difference between revisions of "PAP Technology"

From Apnea Board Wiki
Jump to: navigation, search

 
Line 1: Line 1:
'''Overview of device types'''
+
 
 +
== Introduction ==
 +
Positive airway pressure (PAP) is the primary treatment of sleep-disordered breathing including obstructive sleep apnea, central sleep apnea, and sleep-related hypoventilation. The most common form – continuous positive airway pressure (CPAP) – maintains a continuous level of PAP in a spontaneously breathing patient. Other forms that provide noninvasive positive pressure ventilation include bilevel positive airway pressure (BiPAP), adaptive servoventilation (SV), and volume-assured pressure support (VAPS). This review will highlight the differences in the device types as well as features that help with the functioning and comfort.
 +
PAP equipment involves three basic parts: a device with a motor, a mask that covers either or both the mouth and nose, and a tube that connects the device to the mask. PAP has improved greatly since Colin Sullivan invented CPAP in June 1980 in Australia, using a paint compressor attached to pool tubing and a mask made from a plaster cast glued to the patient’s face. Major landmarks in the evolution of PAP are the first commercially available units by Respironics in 1985 and the self-sealing “bubble mask” in 1990.1
 +
Current noninvasive positive pressure ventilation units are much more complex and may include an air filter, sensors (motor speed, gas volumetric flow rate, pressure, snore transducer), microprocessor-based controller, data storage, multilingual displays, and humidifier with heated tubing.
 +
 
 +
We reviewed literature from the manufacturers, patents, and published literature to provide an understanding of the different algorithms, features, and clinical applications of the various PAP devices.
 +
 
 +
== Overview of device types ==
 
'''CPAP''' maintains a continuous Positive Airway Pressure (PAP) throughout inspiration and expiration. Autoadjusting (Auto) CPAP can gradually increase or decrease the pressure based on respiratory events, but similarly maintains the same pressure throughout the respiratory cycle. This can be helpful for patients who may need a higher pressure in rapid eye movement (REM) or supine position, but cannot tolerate the higher pressure through the entire night. AutoCPAP can also be used diagnostically to determine a fixed pressure setting.
 
'''CPAP''' maintains a continuous Positive Airway Pressure (PAP) throughout inspiration and expiration. Autoadjusting (Auto) CPAP can gradually increase or decrease the pressure based on respiratory events, but similarly maintains the same pressure throughout the respiratory cycle. This can be helpful for patients who may need a higher pressure in rapid eye movement (REM) or supine position, but cannot tolerate the higher pressure through the entire night. AutoCPAP can also be used diagnostically to determine a fixed pressure setting.
  
Line 10: Line 18:
 
'''Volume-assured pressure support (VAPS)''' is a variable bilevel PAP that allows the target volume or ventilation to be programmed, which allows more control of ventilation. This is useful for patients with combined periodic breathing and hypoventilation or patients with REM-related hypoventilation related to conditions like chronic obstructive pulmonary disease (COPD), neuromuscular disorders, or obesity, who may need different PS levels at different times.
 
'''Volume-assured pressure support (VAPS)''' is a variable bilevel PAP that allows the target volume or ventilation to be programmed, which allows more control of ventilation. This is useful for patients with combined periodic breathing and hypoventilation or patients with REM-related hypoventilation related to conditions like chronic obstructive pulmonary disease (COPD), neuromuscular disorders, or obesity, who may need different PS levels at different times.
  
 +
== Motor/flow generator and transducers ==
 +
In order to provide a constant desired pressure at the patient’s airway, adjustments in flow must be made to account for the loss of pressure between the flow generator and the patient’s airway, as well as for breathing fluctuations and leak.
 +
Transducers monitor the motor speed, airflow, and the pressure at a fixed point downstream from the flow generator. Because the sensor is within the device and not in the mask, the device must calculate the predicted pressure at the mask based on the flow measurements at a different point in the system. The pressure at two points varies with the flow. For turbulent flow, this can be calculated by Flow (q) = constant√(p1 − p2).3 The length and diameter of the tubing and mask characteristics affect the constant value, and so the technician must input the mask and tube type for the microprocessor to make the correct calculations. The mask flow can also be calculated by subtracting the flow through the exhaust of the device from the flow through the tubing.4
 +
In order to maintain a stable mask pressure, the microprocessor must adjust the turbine speed in response to deviations in pressure that occur from leak or normal swings in air pressure from breathing. The flow signal is sent through low and high pass filters to separate the respiratory flow signal from artifacts. Low pass filters exclude large quick deviations in flow (eg, coughs or sneezes) and high pass filters exclude cardiogenic fluctuations. Feedback limits determine if the flow or pressure is beyond the expected range of flow variation at a particular motor speed (eg, break in the tubing), and prevent the device from delivering too much or too little pressure.5 With increasing altitude, fan speed needs to be increased to maintain the same pressure.6 Many devices adjust automatically to altitude.
 +
 +
== Leak compensation ==
 +
Unlike invasive ventilation, leak is an important factor that must be compensated for. Leak affects aspects of performance including pressure delivered, cycle and trigger thresholds, and respiratory event determination. Leak compensation works by constantly monitoring flow and looking for deviations from the expected respiratory flow and will compensate the motor speed for the leak. Because there are normal variations in the patient’s breathing cycle the expected leak is usually averaged over several breaths. If leak is high, auto devices may compensate by lowering the pressure, which may seal the mask and reduce leak.
 +
The leak can be determined from the flow rate at the end of exhalation.7 Normal leak includes that from exhalation ports on the mask, which varies by mask type and pressure level, and unintentional leak from the mouth or around the mask. In general, leak should be under 24 L/min in nasal masks and under 36 L/min in full face masks.
 +
The lips and tongue sometimes act like a one-way valve opening during exhalation, when the pharyngeal pressure is highest. This is called valve leak or expiratory puffs. Expiratory puffs may falsely imply flow limitation, which can cause auto devices to increase pressures unnecessarily.
 +
Some algorithms place less reliance on flow limitation when large leak or expiratory puffs are present.8
 +
 +
== Respiratory cycle determination ==
 +
Determination of the inspiratory and expiratory cycles is essential not only to provide bilevel PAP but also for expiratory pressure relief and determination of inspiratory flow limitation in auto algorithms. The start of inspiration is marked by a switch from negative to positive flow (relative to baseline). The point at which the flow signal switches from positive to negative flow is the start of expiration.
 +
SV and some auto devices use more continuous respiratory cycle determination. ResMed’s servoventilator microprocessor uses fuzzy inference rules looking at the flow rate (relative to mean flow), direction, and size to determine the phase of the respiratory cycle9 (Table 1). Respironics’ servoventilator determines the length of inspiration and expiration of recent breaths to predict the future breath duration and divides the breaths into short time segments (64 ms) to determine the expected mid-inspiration and other points of the cycle.10
 +
 +
== CPAP ==
 +
Most CPAP devices allow for pressure settings between 4 and 20 (all pressures in cm⋅H2O). An EPAP of 4 is the lowest pressure needed to provide enough flow to clear the dead space from the device, tubing, and airway to prevent rebreathing of exhaled air.11 The goal of CPAP is to increase upper airway pressure enough to provide a pneumatic splint to open the airway, which may collapse during inspiration. Typically, the pressure is set to prevent hypopnea, apnea, snoring, flow limitation, and arousals. By providing positive end expiratory pressure, CPAP may recruit alveoli and improve ventilation.
 +
 +
== AutoCPAP ==
 +
The aim of AutoCPAP is to adjust the pressure in response to respiratory events without adjustment to artifacts caused by leak or other factors. AutoCPAP from different companies and different models by the same company have varying definitions of events, responses to obstructive events, and protocols for decreasing the pressure once the breathing stabilizes. These variations are important to understand for appropriate clinical care as they affect the patient’s tolerance of the devices and the clinical efficacy.12–14 If a patient enters REM sleep or changes position, the degree of obstruction may suddenly increase and by the time the device is able to adjust to the needed pressure the patient may have had desaturations or arousals. This is why most studies reporting the equivalence of AutoCPAP to in-lab titration recommend changing the EPAP minimum to the pressure the device is at or below 90–95% of the time.2,15 In our experience, many patients left on AutoCPAP 4–20 are undertreated and may present with awakenings a couple hours into sleep, residual symptoms, or difficulty tolerating PAP. Some patients are sensitive to the pressure changes, so if patients are not doing well with AutoCPAP, fixed CPAP should be tried.
 +
Some of the first AutoCPAPs, like Virtuoso LX smart and SOMNOsmart, only detected vibration-based snore changes making them unresponsive to many significant events.16 Most new AutoCPAP systems use snore detection in combination with flow detection. The flow is sampled many times per second, scaled with a low pass filter to remove artifact, and then a mean flow can be determined for any time length. Peak flow can be a poor measure of breath volume, which can lead to over- or underestimation of an apnea or hypopnea. Respironics uses a weighted peak flow (WPF) method to estimate ventilation, while ResMed uses a scaled low-pass-filtered absolute value of respiratory flow and uses a root mean squared (RMS) technique of the variance of the flow from the mean to compare one moving time period to another. DeVilbiss Intellipap AutoAdjust uses a scaled peak amplitude, while AutoAdjust 2 uses RMS and other filtering techniques to adjust for artifacts in peak flow.
 +
Respironics’ WPF method first determines the inspiratory period, then the inspiratory volume and the points on the inspiratory flow curve that correspond to the 20% and 80% volume. The average flow of all points between the 20% and 80% points is used as the WPF, a measure of ventilation. This method uses WPF values over the prior 4 minutes and determines the average of values between the 80th and 90th percentile. This baseline is used to compare with the current WPF to look for decrease in amplitude, which would indicate apnea or hypopnea.17
 +
ResMed’s RMS method determines ventilation from variance of the flow throughout the entire breath by comparing individual flow points to the mean airflow over a defined time period. The mean airflow is the zero-point between inspiration and expiration, thus variance from this mean divided by two equals the amplitude of the inspiratory flow. By taking the square root of the variance squared, outlying values receive less weight. A moving short time period (eg, one breath or 2 seconds) can be compared to a moving longer period (eg, 5 minutes) to evaluate for apnea or hypopnea.18 Apneas and hypopneas are typically defined as a reduction in ventilation below a percentage of recent breathing for at least 10 seconds, with varying methods used by different devices (Table 2).
 +
Since responding to central apneas can lead to over titration, testing for airway patency allows for differentiation of central from obstructive apneas. Two methods used to test for airway patency include cardiogenic pulsation testing and device-generated pressure oscillations. The first method looks for cardiogenic pulse artifact in the flow, which is only present if the airway is open. In the second method, the device provides single pressure pulse or small oscillation in the flow (eg, 1 cm, 4–5 Hz or forced oscillation technique), which is only reflected back to the flow sensors if the airway is closed.18–20 Respironics uses pressure pulses and also defines an obstructive apnea if there is a larger than expected breath after apnea termination. A mixed apnea can be determined if the airway is open for only part of the flow. ResMed from S9 onward uses force oscillation technique to define central apneas and defines central apneas if leak is .30 L/min.18 DeVilbiss Autoadjust 2 uses a modulating micro-oscillation to determine airway patency during apneas.
 +
In order to evaluate flow limitations, Respironics determines roundness, flatness, skewness, and WPF to rate the most recent four breaths as better, worse, or the same compared to baseline. Roundness is determined by the similarity of the WPF between 5% and 95% values to a sine wave. Flatness is determined by the absolute value of the variance between 20% and 80% of inspiratory flow from the average of all the values in the same period, divided by 80% volume point. Skewness is determined by dividing the average of the highest 5% of flows in the mid third of the breath by the average of the highest 5% of flows in the first third of the breath.17
 +
ResMed also determines flow limitation. S8 AutoSet defines flow limitation using flatness of an inspiratory breath. The flatness index is calculated by the RMS deviation from unit scaled flow calculated over the middle 50% of a normalized inspiratory breath.4 From the S9 onward, flow limitation is calculated using a combination of flatness index, breath shape index, ventilation change, and breath duty cycle. Ventilation change is the ratio of the current breath ventilation to recent 3-minute ventilation. Breath duty cycle is the ratio of current breath time of inspiration to total breath time of recent 5 minutes. If a breath is severely flow limited, the flow limitation index will be closer to one and when the breath is normal or round, the flow limitation index will be zero.8
 +
Table 2 summarizes the differences between the algorithms for the ResMed AutoSet device,4,8 ResMed AutoSet for Her,8 Respironics System One REMstar Auto,17 and DeVilbiss IntelliPAP AutoAdjust and AutoAdjust 2.21 ResMed AutoSet evaluates flow every breath looking for apneas, snore, and flow limitation, but responds to flow limitation on a 3-breath average, has faster decreases in the absence of flow limitation and has a higher rate of pressure change to all responses (apnea, snore, and flow limitation) than AutoSet for Her.8,18
 +
In comparison, ResMed AutoSet for Her evaluates the flow for every breath looking for apneas, snore, and flow limitation, and delivers a proportional increase in pressure depending on the degree of deviation of the event from normal, modulated by the current pressure setting and leak rates. If pressure is .10, then the response to flow limitation reduces and a louder snore is required to produce a response.8 Both AutoSet for Her and AutoSet respond less as leak gets higher.
 +
Respironics REMstar Auto uses layers of control including ramp, leak, snore, apnea/hypopnea, variable breathing, and flow limitation. If there is no snore, apnea/hypopnea, variable breathing, or flow limitation breathing for 3–5 minutes, it will enter a testing period in which it will first decrease the pressure until either Pminimum or the flow characteristics (peak, flatness, roundness, and skew) worsen, which is the Pcritical, then quickly increase by 1.5 and holds for 10 minutes unless further events or flow limitation occurs. If there is snore, apnea/hypopnea, variable breathing or flow limitation, the pressure increases by 0.5/min until there is no further improvement or worsening, then decreases by 1.5, which is set as the Poptimal pressure. REMstar also uses several mechanisms to avoid over titration, which include nonresponsive apnea/hypopnea logic, variable breathing, and leak control (Table 2).17,22
 +
Most devices start at the set EPAP minimum (EPAPmin) each night. Respironics REMstar Pro and REMstar Auto have CPAP check mode, which checks the 90% pressure every 30 hours, then decides whether to leave the EPAP unchanged, or changes the EPAP up or down by one but not more than three from set EPAP.23
 +
DeVilbiss’s IntelliPAP AutoAdjust allows setting of amplitude and duration cut-points for apneas and hypopneas to change sensitivity. AutoAdjust does not detect flow limitation and defines central apneas as ,5% of airflow for 10 seconds.21 It continuously scores events, but only decides once per minute whether to adjust pressures. AutoAdjust 2 similarly adjusts pressures once per minute, but also responds to flow limitation based on inspiratory flatness. It uses modulating micro-oscillation during apneas to test for patency and has an algorithm to define periodic breathing, looking for cyclic breathing as short as a 20-second cycle. AutoAdjust 2 holds or lowers pressures in response to central apneas and periodic breathing.
 +
 +
== BiLevel/BiPAP ==
 +
BiPAP provides a higher pressure during inhalation and lower pressure during exhalation. Pressures generally range from EPAP minimum of four to IPAP maximum of 25–30. Most devices use a flow trigger to determine when to change to IPAP. The trigger is set above zero flow to sense a significant patient effort. Different methods including flow, shape, and volume are used to cycle to EPAP in efforts to minimize dyssynchrony. The flow cycle algorithm changes to EPAP when the flow drops below a percentage (eg, 25%) of the peak flow so the patient will not encounter resistance to exhalation.24 Shape cycling algorithm uses shape of flow,25 and volume cycle algorithm uses exhaled volume to cycle to EPAP. There can be significant variation between devices in terms of how quickly pressure levels are met and whether a device has a delay or premature cycle, especially in the setting of leaks.26 If there is a mismatch between the patient’s respiratory cycle and the device control cycle there can be patient discomfort.
 +
In older BiPAP devices, the motor was braked at the transition point from higher to lower pressures and the motor was accelerated when the device transitioned from lower to higher pressure, which affected synchrony and tolerability. One method to improve comfort is to allow the blower motor to spin freely on transition between inspiration and expiration. Newer devices allow for a smoother transition in pressure changes, and waveforms can be square, exponential, ramp, or sinusoidal. ResMed has a sharkfin-shaped “Easy-Breathe” waveform.27 The shape of the waveform may be affected by the compliance and resistance of the patient’s respiratory system and the breathing effort, as well as mechanical constraints of blower momentum and propagation delays. In general, BiPAP provides a square wave of PS, but manual or automatic adjustments can give more of a smooth pressure BiPAP provides a higher pressure during inhalation and lower pressure during exhalation. Pressures generally range from EPAP minimum of four to IPAP maximum of 25–30. Most devices use a flow trigger to determine when to change to IPAP. The trigger is set above zero flow to sense a significant patient effort. Different methods including flow, shape, and volume are used to cycle to EPAP in efforts to minimize dyssynchrony. The flow cycle algorithm changes to EPAP when the flow drops below a percentage (eg, 25%) of the peak flow so the patient will not encounter resistance to exhalation.24 Shape cycling algorithm uses shape of flow,25 and volume cycle algorithm uses exhaled volume to cycle to EPAP. There can be significant variation between devices in terms of how quickly pressure levels are met and whether a device has a delay or premature cycle, especially in the setting of leaks.26 If there is a mismatch between the patient’s respiratory cycle and the device control cycle there can be patient discomfort.
 +
In older BiPAP devices, the motor was braked at the transition point from higher to lower pressures and the motor was accelerated when the device transitioned from lower to higher pressure, which affected synchrony and tolerability. One method to improve comfort is to allow the blower motor to spin freely on transition between inspiration and expiration. Newer devices allow for a smoother transition in pressure changes, and waveforms can be square, exponential, ramp, or sinusoidal. ResMed has a sharkfin-shaped “Easy-Breathe” waveform.27 The shape of the waveform may be affected by the compliance and resistance of the patient’s respiratory system and the breathing effort, as well as mechanical constraints of blower momentum and propagation delays. In general, BiPAP provides a square wave of PS, but manual or automatic adjustments can give more of a smooth pressure air trapping and reduced tidal volume if expiration time is too short.25
 +
Cycle sensitivity sets the level of inspiratory flow below which the device changes from IPAP to EPAP. High cycle setting is recommended when shortened Ti is needed, such as for COPD or if the patient complains that the breaths are too long. Low cycle is recommended when longer Ti is needed for neuromuscular diseases, weak respiratory effort, or stiff lungs, or if the patient complains that the pressure seems to switch from IPAP to EPAP too quickly.
 +
BiPAP can be triggered by spontaneous, timed or spontaneous/timed (ST) modes. In spontaneous mode, inspiration is only triggered when the device senses a flow change. Large leak may cause the trigger to fail if the device does not appropriately adjust. Timed mode triggers at a fixed rate and makes no attempt to synchronize with the patient’s breathing, which can result in breath stacking and patient discomfort. ST mode changes pressures with spontaneous breathing efforts, but if the patient has not triggered a breath by a set respiratory rate, then the device will trigger a breath.
 +
ST mode is most often used for primary central apnea or central apneas due to respiratory depression. ST mode may also be used for neuromuscular disease patients, whose respiratory efforts fall during REM sleep, which may make them unable to trigger inspiration.28 Timed mode is often used for patients with severe neuromuscular weakness or spinal cord injury, who are unable to trigger inspiration.
 +
BiPAP may worsen central apneas due to CSR by increasing breath size of spontaneous breaths and forcing a triggered breath during the apneic portion, which is when the partial pressure of carbon dioxide (Pco2) level is already at its lowest.29 By further decreasing the Pco2, respiratory drive is reduced further and the duration of the apnea will often lengthen, although the oxygenation may improve with the deeper or forced breath. Sometimes the improved oxygenation and PS will help to eventually stabilize the patient’s breathing,30 but in our experience patients with CSR often find BiPAP intolerable or still have a suboptimal clinical response including fluctuations in the respirations and electroencephalogram.
 +
 +
== Auto BiLevel/BiPAP ==
 +
Like AutoCPAP, not all AutoBiPAP devices work in the same way. Some devices only allow a fixed PS, others set a PS maximum (PSmax), and others allow for both PS minimum (PSmin) and PSmax. Thus AutoBiPAP may not provide adequate ventilator support if PSmin cannot be set. AutoBiPAP devices generally do not have an ST option, so are not recommended for central apneas.
 +
ResMed’s VPAP AutoBiPAP and DeVilbiss AutoBiPAP have a fixed set PS. Respironics Series 50 AutoBiPAP fixes PSmin at two and allows setting PSmax, while Series 60 AutoBiPAP allows setting both PSmin and PSmax. Within the limits of PSmin and PSmax, Respironics AutoBiPAP changes EPAP in response to apneas (two apneas or one apnea and one hypopnea) and snoring, and IPAP in response to hypopneas (two hypopneas) and flow limitation, with algorithms similar to REMstar AutoCPAP.31
 +
 +
== Adaptive servoventilation (ASV) ==
 +
Because higher PAP pressures and high PS can induce periodic breathing and CSR, devices have been developed to try to even out the breathing over several breaths. These devices include ResMed VPAP AdaptSV (equivalent to Teijin AutoSet CS) with ASV setting, AirCurve ASV, which has been renamed AirCurve CS PaceWave with ASV and ASVAuto settings, and Respironics BiPAP AutoSV Advanced. Another device, SOMNOvent CR, is available outside of the US from Weinmann (Table 4).
 +
ResMed’s standard ASV uses a set fixed EPAP, samples flow 50 times per second, and alters IPAP throughout inspiration to achieve target minute ventilation. The PS range can be 0–20, but default is usually a PSmin of three and PSmax of 15. The device calculates a target minute ventilation based on the recent average weighted minute ventilation, weighted toward the last 3 minutes. ASV uses fuzzy logic to determine the part of the respiratory cycle and whether the current ventilation is below or above the desired target and then adjusts the PS throughout the cycle to achieve that target, thus avoiding abrupt pressure changes. The change in pressure is calculated by multiplying a gain of 0.3 cm H2O/L/min/s by the difference between the target minute ventilation and the actual minute ventilation. An automatic backup rate starts with the current spontaneous rate based on moving average calculated over several breaths and gradually adapts during an apnea to 15 bpm.9 ASVAuto also adjusts the EPAP level similar to the AutoSet algorithm in response to obstructive apneas, flow limitation, and snoring.32
 +
The hope is that by stabilizing breathing, the periodic breathing pattern will subside. If the device is cycling the pressures frequently to maintain the target ventilation, it indicates that the underlying periodic pattern is still present and often the patient will either not tolerate the device or there will be a suboptimal clinical response.33
 +
Respironics BiPAP AutoSV Advanced is set with EPAP minimum and maximum, PSmin and PSmax, max pressure, and auto or fixed rate. Ti, rise time, and Bi-Flex can also be set for comfort. The level of PS is targeted based on instantaneous average inspiratory flow, which is the sum of the inspiratory flows during a time divided by the number of samples during a time in order to adjust for spurious values. The target peak flow is generally set at 90%–95% of the mean peak flow of the last 4 minutes. In an attempt to stabilize breathing in the setting of obstructive features (apnea [,20% flow], hypopnea [20%–60% flow], and snoring), the target peak flow increases from 95% of the mean inspiratory peak flows over the last 4 minutes to the 60th percentile of the inspiratory peak flow values. The target peak flow is also increased to 60th percentile if CSR features are noted based on a CSR index, which measures similarity to a CSR pattern or a flow index that measures fluctuations in breath size.34
 +
The respiratory cycle of AutoSV Advanced is determined by using the average length of the breathing cycle over recent breaths and calculating the expected midpoint of inspiration. Compared to multiple small adjustments in the PS throughout the breath cycle with ResMed’s ASV, the inspiratory PS is determined based on the prior breath’s PS plus a gain based on a moving average of the pressure needed in the prior 30 breaths multiplied by the difference between the target peak inspiratory flow and the current breath’s peak inspiratory flow. An intrabreath PS is given if the actual flow is less than target flow in the 100 ms prior to the expected halfway point of the inspiration of the current breath. If actual flow is larger than target flow, the PS will be decreased for the following breath.34
 +
The EPAP adjustment algorithm of AutoSV Advanced is similar to REMstar Auto algorithm, but uses a triggered breath rather than forced oscillation to differentiate obstructive from open airway events.32 The automatic backup rate of AutoSV Advanced is determined based on a moving window of the last 12 spontaneous breaths. A mandatory breath is given if the breath does not occur within certain parameters, with a minimum breath rate of 8–10 bpm. A fixed backup rate can also be set.
 +
The older BiPAP AutoSV did not automatically titrate the expiratory pressure, and the algorithm for the automatic backup rate was not proportional to the baseline breathing rate, but it would give a breath if no spontaneous breath occurred within 8 seconds of end of expected breath length or within 4 seconds, if there was recent triggered breath.35 Respironics BiPAP AutoSV Advanced has been found to be more effective than the older BiPAP AutoSV.35 SV, which targets recent ventilation (ASV) or recent peak flow (AutoSV) is not appropriate for managing patients with respirator insufficiency, for whom BiPAP or VAPS should be considered.
 +
 +
== Volume-assured pressure support ==
 +
Respironics AVAPS (average VAPS) and ResMed iVAPS (intelligent VAPS) adjust the PS in order to maintain target average ventilation over several breaths (Table 5). This mode of PAP is often helpful for patients with respiratory insufficiency due to neuromuscular and restrictive conditions in which respiratory effort varies during sleep or who need PAP during the day, COPD patients with risk of hypoventilation, and for obesity hypoventilation patients who may need compensation based on positional and sleep stage changes. Because many patients have much worse hypoventilation in REM, BiPAP with a fixed PS may provide too much pressure in NREM, which may lead to intolerance or complex sleep apnea and may not provide enough PS in REM to control Pco2 levels. Benefits of VAPS over BiPAP can include maintaining volumes in the setting of altered patient effort based on sleep stage or altered lung mechanics related to position. Lesser PS during wake may increase comfort and aid sleep onset, reduce risk of barotrauma, and lower pressures for most of the time.36 A randomized trial of iVAPS vs BiPAP found that iVAPS delivered a lower mean PS for the oxygenation and transcutaneous Pco2 level and had better adherence than BiPAP.37
 +
Both AVAPS and iVAPS adjust PS and respiratory rate to reach a defined target with the goal of stabilizing the Pco2, which relates directly to alveolar ventilation. With a target tidal volume (eg, AVAPS), if there is a large variance in the respiratory rate, there can be fluctuations in the alveolar ventilation and thus Pco2. By targeting estimated alveolar ventilation (minute ventilation–estimated dead space ventilation; eg, iVAPS), variations in respiratory rate should not affect alveolar ventilation or Pco2 as long as the estimated dead space equals physiologic dead space. The device estimates the anatomic dead space using height.38 However, patients with lung diseases, such as emphysema, have increased physiologic dead space that would be underestimated by the above equation, and thus their alveolar ventilation can be much lower than the estimated alveolar ventilation. Thus, emphysema patients may require high target alveolar ventilation to achieve an adequate actual alveolar ventilation. Alternatively, the “height” can be entered artificially high for emphysema patients, thus the calculated dead space will be closer to physiologic dead space, and therefore iVAPS more closely maintains the actual alveolar ventilation.
 +
Respironics AVAPS targets an average tidal volume over several breaths. Typically, the target tidal volume is set based on 6–10 mL/kg ideal body weight. It calculates the average PS provided to the patient over the prior 2 minutes in order to achieve a particular tidal volume. If average recent ventilation is less than target volume, IPAP for the next breath is increased. PS will change at a rate of 2/min if there is unstable breathing and 1/min if there is stable breathing. AVAPS-AE model (and also AVAPS on Trilogy 100 Ventilator) can set maximum rate of pressure change from 1/min to 5/min. AVAPS uses square waveform with Ti and rise time settings. EPAP is fixed with AVAPS, but AVAPS-AE adjusts EPAP similar to Respironics REMstar Auto with a searching protocol between EPAP minimum and maximum. AVAPS either uses a fixed rate or auto backup rate set at 2 bpm lower than the rate of the last six spontaneous breaths.39
 +
ResMed iVAPS uses a similar servoventilator with fuzzy logic for determining respiratory phase as adaptive SV. Unlike adaptive SV, the goal ventilation is set to a target alveolar ventilation, which is defined as minute ventilation minus anatomical dead space ventilation. iVAPS alters the gain every 8/50th second throughout the inspiratory cycle to achieve the target ventilation with a smooth parabolic transition that can be modified with rise time, Ti, and cycle and trigger sensitivities. EPAP is fixed like adaptive SV.40
 +
iVAPS’ intelligent backup rate function uses two-third of the set target patient rate as the backup rate during spontaneous breathing and switches during apneas to the set patient target rate apnea. This reduces potential dyssynchrony during spontaneous breathing, while providing ventilation during apneas at a lower PS than if the backup rate remained lower.41
 +
The iVAPS ventilation and rate targets can be configured using the Learn Target feature. While the patient is awake and comfortably breathing at rest, the clinician initiates the Learn Target session, which typically lasts between 15 minutes and 20 minutes and monitors the breathing while on a base EPAP pressure of 6. It uses the average respiratory rate, and since metabolic rate decreases in sleep, it uses 90% of the average estimated alveolar ventilation of the last 5 minutes of the session to propose a target patient rate and target alveolar ventilation, which can then be set by the
 +
clinician.42
 +
 +
== Other features of PAP ==
 +
Humidification, heated tubing, ramp, automatic start and stop functions, alarms, and expiratory pressure relief are device functions that are designed to improve patient comfort and compliance (Table 6).
 +
Humidifiers include a water chamber with a heating plate through which the airflow is blown. Increasing the warmth of the heating plate increases humidification. Temperature sensors or humidification sensors allow for regulation of temperature or humidification level. Increasing humidification in the air helps reduce nasal irritation and congestion that can result from the airflow on the nasal passages.43 If the humidified air cools in the tubing, water may condense in the tube or mask, commonly referred to as “rainout”. Insulation sleeves that wrap around the tubing or heated tubing, which includes a heating element in the tubing, can increase humidification and eliminate “rainout”. The controls for the heated tubing are often linked to the warming level of the plate, but some devices allow for dissociation of the controls, which may further help with comfort in some patients. Different amounts of humidification may be needed depending on the external humidity and temperature.
 +
For travel, standard PAP devices can be used with external battery packs or with converters to allow them to be powered by a car, boat, or other vehicles. There are also small battery-powered units weighing around 10 oz, such as Z1 CPAP and Z1 Auto from HDM, compared to 48 oz for Respironics System One and 44 oz for ResMed AirSense S10.
 +
 +
== Data collection and display ==
 +
Data from the device can be retrieved on the interface with a data card, cable, and wireless or by cellular and bluetooth to an online platform. Data cards can either be used to download locally or to an online website, which allows for sharing. Summary data from the last month is often viewable on the device. DeVilbiss IntelliPAP devices use codes that represent different data sets that their website uses to generate a report.
 +
Data collected varies among devices and can include pressure settings, leak, average, 90%–95% pressures and maximum pressures, PS, tidal volumes, minute ventilation, and apnea hypopnea index. Some devices report more detailed data about respiratory events, which may include central, mixed, obstructive and undetermined apneas, hypopneas, flow limitation, snoring, expiratory puffs, percentage of time in periodic breathing, tidal volume, and minute ventilation. Reports can show summary data over days and months as well as detailed data with the timing of events over the course of one night. Often data can be searched for a 30 day compliance period having over 4 hours of use on 70% of the nights. Respironics System One devices can also show full night waveform tracings with scored events and pressure settings. An oximetry module can be connected to ResMed’s AirSense device to allow for saturation data. More data about adherence tracking systems are available in a review by Schwab et al.44
 +
 +
== Conclusion
 +
There are a wide range of PAP devices and a wide range of different algorithms used to provide PAP to treat sleep-disordered breathing. For this reason, devices in the same category may differ greatly in their clinical efficacy and comfort. Understanding how PAP devices function can help the clinician select the best PAP device, appropriately titrate, troubleshoot, and optimize settings for a particular patient. Many comfort features have improved the function and performance of devices, which allows many patients who have been unable to tolerate PAP in the past to become compliant. Many devices track compliance and provide important clinical data to help care for the patients.
  
  
Line 79: Line 161:
  
 
Abbreviations: A/H, apnea/hypopnea; AutoCPAP, auto-adjusting continuous positive airway pressure; CPAP, continuous positive airway pressure; FL, flow limitation; FOT, forced oscillation technique; Hz, hertz; max, maximum; min, minute; NA, not applicable; NRAH, nonresponse apnea hypopnea logic; OA, obstructive apnea; Pcrit, critical pressure; Pmin, minimum pressure; Popt, optimal pressure; RMS, root mean square; s, second; VB, variable breathing; WPF, weighted peak flow.
 
Abbreviations: A/H, apnea/hypopnea; AutoCPAP, auto-adjusting continuous positive airway pressure; CPAP, continuous positive airway pressure; FL, flow limitation; FOT, forced oscillation technique; Hz, hertz; max, maximum; min, minute; NA, not applicable; NRAH, nonresponse apnea hypopnea logic; OA, obstructive apnea; Pcrit, critical pressure; Pmin, minimum pressure; Popt, optimal pressure; RMS, root mean square; s, second; VB, variable breathing; WPF, weighted peak flow.
 +
 +
 +
[[File:Technology update Treatment of sleep-disordered breathing.pdf]]

Latest revision as of 03:07, 19 June 2019

Introduction

Positive airway pressure (PAP) is the primary treatment of sleep-disordered breathing including obstructive sleep apnea, central sleep apnea, and sleep-related hypoventilation. The most common form – continuous positive airway pressure (CPAP) – maintains a continuous level of PAP in a spontaneously breathing patient. Other forms that provide noninvasive positive pressure ventilation include bilevel positive airway pressure (BiPAP), adaptive servoventilation (SV), and volume-assured pressure support (VAPS). This review will highlight the differences in the device types as well as features that help with the functioning and comfort. PAP equipment involves three basic parts: a device with a motor, a mask that covers either or both the mouth and nose, and a tube that connects the device to the mask. PAP has improved greatly since Colin Sullivan invented CPAP in June 1980 in Australia, using a paint compressor attached to pool tubing and a mask made from a plaster cast glued to the patient’s face. Major landmarks in the evolution of PAP are the first commercially available units by Respironics in 1985 and the self-sealing “bubble mask” in 1990.1 Current noninvasive positive pressure ventilation units are much more complex and may include an air filter, sensors (motor speed, gas volumetric flow rate, pressure, snore transducer), microprocessor-based controller, data storage, multilingual displays, and humidifier with heated tubing.

We reviewed literature from the manufacturers, patents, and published literature to provide an understanding of the different algorithms, features, and clinical applications of the various PAP devices.

Overview of device types

CPAP maintains a continuous Positive Airway Pressure (PAP) throughout inspiration and expiration. Autoadjusting (Auto) CPAP can gradually increase or decrease the pressure based on respiratory events, but similarly maintains the same pressure throughout the respiratory cycle. This can be helpful for patients who may need a higher pressure in rapid eye movement (REM) or supine position, but cannot tolerate the higher pressure through the entire night. AutoCPAP can also be used diagnostically to determine a fixed pressure setting.

Most CPAP devices allow for pressure settings between 4 and 20 (all pressures in cm⋅H2O). An EPAP of 4 is the lowest pressure needed to provide enough flow to clear the dead space from the device, tubing, and airway to prevent rebreathing of exhaled air. The goal of CPAP is to increase upper airway pressure enough to provide a pneumatic splint to open the airway, which may collapse during inspiration. Typically, the pressure is set to prevent hypopnea, apnea, snoring, flow limitation, and arousals. By providing positive end expiratory pressure, CPAP may recruit alveoli and improve ventilation.

BiPAP provides a higher pressure during inspiration and lower pressure during expiration. This may improve tolerance and help with ventilation. A backup rate can be added to give a breath with weak or absent respiratory effort. AutoBiPAP may adjust either the expiratory positive airway pressure (EPAP) and inspiratory positive airway pressure (IPAP) with a fixed pressure support (PS) or may adjust them independently.

SV is a bilevel system that continuously changes the inspiratory PS on a breath-by-breath basis in order to achieve a target ventilation or flow for a more constant breathing pattern, especially in the treatment of periodic breathing or Cheyne–Stokes respiration (CSR). Auto forms of SV also increase EPAP in response to obstruction.

Volume-assured pressure support (VAPS) is a variable bilevel PAP that allows the target volume or ventilation to be programmed, which allows more control of ventilation. This is useful for patients with combined periodic breathing and hypoventilation or patients with REM-related hypoventilation related to conditions like chronic obstructive pulmonary disease (COPD), neuromuscular disorders, or obesity, who may need different PS levels at different times.

Motor/flow generator and transducers

In order to provide a constant desired pressure at the patient’s airway, adjustments in flow must be made to account for the loss of pressure between the flow generator and the patient’s airway, as well as for breathing fluctuations and leak. Transducers monitor the motor speed, airflow, and the pressure at a fixed point downstream from the flow generator. Because the sensor is within the device and not in the mask, the device must calculate the predicted pressure at the mask based on the flow measurements at a different point in the system. The pressure at two points varies with the flow. For turbulent flow, this can be calculated by Flow (q) = constant√(p1 − p2).3 The length and diameter of the tubing and mask characteristics affect the constant value, and so the technician must input the mask and tube type for the microprocessor to make the correct calculations. The mask flow can also be calculated by subtracting the flow through the exhaust of the device from the flow through the tubing.4 In order to maintain a stable mask pressure, the microprocessor must adjust the turbine speed in response to deviations in pressure that occur from leak or normal swings in air pressure from breathing. The flow signal is sent through low and high pass filters to separate the respiratory flow signal from artifacts. Low pass filters exclude large quick deviations in flow (eg, coughs or sneezes) and high pass filters exclude cardiogenic fluctuations. Feedback limits determine if the flow or pressure is beyond the expected range of flow variation at a particular motor speed (eg, break in the tubing), and prevent the device from delivering too much or too little pressure.5 With increasing altitude, fan speed needs to be increased to maintain the same pressure.6 Many devices adjust automatically to altitude.

Leak compensation

Unlike invasive ventilation, leak is an important factor that must be compensated for. Leak affects aspects of performance including pressure delivered, cycle and trigger thresholds, and respiratory event determination. Leak compensation works by constantly monitoring flow and looking for deviations from the expected respiratory flow and will compensate the motor speed for the leak. Because there are normal variations in the patient’s breathing cycle the expected leak is usually averaged over several breaths. If leak is high, auto devices may compensate by lowering the pressure, which may seal the mask and reduce leak. The leak can be determined from the flow rate at the end of exhalation.7 Normal leak includes that from exhalation ports on the mask, which varies by mask type and pressure level, and unintentional leak from the mouth or around the mask. In general, leak should be under 24 L/min in nasal masks and under 36 L/min in full face masks. The lips and tongue sometimes act like a one-way valve opening during exhalation, when the pharyngeal pressure is highest. This is called valve leak or expiratory puffs. Expiratory puffs may falsely imply flow limitation, which can cause auto devices to increase pressures unnecessarily. Some algorithms place less reliance on flow limitation when large leak or expiratory puffs are present.8

Respiratory cycle determination

Determination of the inspiratory and expiratory cycles is essential not only to provide bilevel PAP but also for expiratory pressure relief and determination of inspiratory flow limitation in auto algorithms. The start of inspiration is marked by a switch from negative to positive flow (relative to baseline). The point at which the flow signal switches from positive to negative flow is the start of expiration. SV and some auto devices use more continuous respiratory cycle determination. ResMed’s servoventilator microprocessor uses fuzzy inference rules looking at the flow rate (relative to mean flow), direction, and size to determine the phase of the respiratory cycle9 (Table 1). Respironics’ servoventilator determines the length of inspiration and expiration of recent breaths to predict the future breath duration and divides the breaths into short time segments (64 ms) to determine the expected mid-inspiration and other points of the cycle.10

CPAP

Most CPAP devices allow for pressure settings between 4 and 20 (all pressures in cm⋅H2O). An EPAP of 4 is the lowest pressure needed to provide enough flow to clear the dead space from the device, tubing, and airway to prevent rebreathing of exhaled air.11 The goal of CPAP is to increase upper airway pressure enough to provide a pneumatic splint to open the airway, which may collapse during inspiration. Typically, the pressure is set to prevent hypopnea, apnea, snoring, flow limitation, and arousals. By providing positive end expiratory pressure, CPAP may recruit alveoli and improve ventilation.

AutoCPAP

The aim of AutoCPAP is to adjust the pressure in response to respiratory events without adjustment to artifacts caused by leak or other factors. AutoCPAP from different companies and different models by the same company have varying definitions of events, responses to obstructive events, and protocols for decreasing the pressure once the breathing stabilizes. These variations are important to understand for appropriate clinical care as they affect the patient’s tolerance of the devices and the clinical efficacy.12–14 If a patient enters REM sleep or changes position, the degree of obstruction may suddenly increase and by the time the device is able to adjust to the needed pressure the patient may have had desaturations or arousals. This is why most studies reporting the equivalence of AutoCPAP to in-lab titration recommend changing the EPAP minimum to the pressure the device is at or below 90–95% of the time.2,15 In our experience, many patients left on AutoCPAP 4–20 are undertreated and may present with awakenings a couple hours into sleep, residual symptoms, or difficulty tolerating PAP. Some patients are sensitive to the pressure changes, so if patients are not doing well with AutoCPAP, fixed CPAP should be tried. Some of the first AutoCPAPs, like Virtuoso LX smart and SOMNOsmart, only detected vibration-based snore changes making them unresponsive to many significant events.16 Most new AutoCPAP systems use snore detection in combination with flow detection. The flow is sampled many times per second, scaled with a low pass filter to remove artifact, and then a mean flow can be determined for any time length. Peak flow can be a poor measure of breath volume, which can lead to over- or underestimation of an apnea or hypopnea. Respironics uses a weighted peak flow (WPF) method to estimate ventilation, while ResMed uses a scaled low-pass-filtered absolute value of respiratory flow and uses a root mean squared (RMS) technique of the variance of the flow from the mean to compare one moving time period to another. DeVilbiss Intellipap AutoAdjust uses a scaled peak amplitude, while AutoAdjust 2 uses RMS and other filtering techniques to adjust for artifacts in peak flow. Respironics’ WPF method first determines the inspiratory period, then the inspiratory volume and the points on the inspiratory flow curve that correspond to the 20% and 80% volume. The average flow of all points between the 20% and 80% points is used as the WPF, a measure of ventilation. This method uses WPF values over the prior 4 minutes and determines the average of values between the 80th and 90th percentile. This baseline is used to compare with the current WPF to look for decrease in amplitude, which would indicate apnea or hypopnea.17 ResMed’s RMS method determines ventilation from variance of the flow throughout the entire breath by comparing individual flow points to the mean airflow over a defined time period. The mean airflow is the zero-point between inspiration and expiration, thus variance from this mean divided by two equals the amplitude of the inspiratory flow. By taking the square root of the variance squared, outlying values receive less weight. A moving short time period (eg, one breath or 2 seconds) can be compared to a moving longer period (eg, 5 minutes) to evaluate for apnea or hypopnea.18 Apneas and hypopneas are typically defined as a reduction in ventilation below a percentage of recent breathing for at least 10 seconds, with varying methods used by different devices (Table 2). Since responding to central apneas can lead to over titration, testing for airway patency allows for differentiation of central from obstructive apneas. Two methods used to test for airway patency include cardiogenic pulsation testing and device-generated pressure oscillations. The first method looks for cardiogenic pulse artifact in the flow, which is only present if the airway is open. In the second method, the device provides single pressure pulse or small oscillation in the flow (eg, 1 cm, 4–5 Hz or forced oscillation technique), which is only reflected back to the flow sensors if the airway is closed.18–20 Respironics uses pressure pulses and also defines an obstructive apnea if there is a larger than expected breath after apnea termination. A mixed apnea can be determined if the airway is open for only part of the flow. ResMed from S9 onward uses force oscillation technique to define central apneas and defines central apneas if leak is .30 L/min.18 DeVilbiss Autoadjust 2 uses a modulating micro-oscillation to determine airway patency during apneas. In order to evaluate flow limitations, Respironics determines roundness, flatness, skewness, and WPF to rate the most recent four breaths as better, worse, or the same compared to baseline. Roundness is determined by the similarity of the WPF between 5% and 95% values to a sine wave. Flatness is determined by the absolute value of the variance between 20% and 80% of inspiratory flow from the average of all the values in the same period, divided by 80% volume point. Skewness is determined by dividing the average of the highest 5% of flows in the mid third of the breath by the average of the highest 5% of flows in the first third of the breath.17 ResMed also determines flow limitation. S8 AutoSet defines flow limitation using flatness of an inspiratory breath. The flatness index is calculated by the RMS deviation from unit scaled flow calculated over the middle 50% of a normalized inspiratory breath.4 From the S9 onward, flow limitation is calculated using a combination of flatness index, breath shape index, ventilation change, and breath duty cycle. Ventilation change is the ratio of the current breath ventilation to recent 3-minute ventilation. Breath duty cycle is the ratio of current breath time of inspiration to total breath time of recent 5 minutes. If a breath is severely flow limited, the flow limitation index will be closer to one and when the breath is normal or round, the flow limitation index will be zero.8 Table 2 summarizes the differences between the algorithms for the ResMed AutoSet device,4,8 ResMed AutoSet for Her,8 Respironics System One REMstar Auto,17 and DeVilbiss IntelliPAP AutoAdjust and AutoAdjust 2.21 ResMed AutoSet evaluates flow every breath looking for apneas, snore, and flow limitation, but responds to flow limitation on a 3-breath average, has faster decreases in the absence of flow limitation and has a higher rate of pressure change to all responses (apnea, snore, and flow limitation) than AutoSet for Her.8,18 In comparison, ResMed AutoSet for Her evaluates the flow for every breath looking for apneas, snore, and flow limitation, and delivers a proportional increase in pressure depending on the degree of deviation of the event from normal, modulated by the current pressure setting and leak rates. If pressure is .10, then the response to flow limitation reduces and a louder snore is required to produce a response.8 Both AutoSet for Her and AutoSet respond less as leak gets higher. Respironics REMstar Auto uses layers of control including ramp, leak, snore, apnea/hypopnea, variable breathing, and flow limitation. If there is no snore, apnea/hypopnea, variable breathing, or flow limitation breathing for 3–5 minutes, it will enter a testing period in which it will first decrease the pressure until either Pminimum or the flow characteristics (peak, flatness, roundness, and skew) worsen, which is the Pcritical, then quickly increase by 1.5 and holds for 10 minutes unless further events or flow limitation occurs. If there is snore, apnea/hypopnea, variable breathing or flow limitation, the pressure increases by 0.5/min until there is no further improvement or worsening, then decreases by 1.5, which is set as the Poptimal pressure. REMstar also uses several mechanisms to avoid over titration, which include nonresponsive apnea/hypopnea logic, variable breathing, and leak control (Table 2).17,22 Most devices start at the set EPAP minimum (EPAPmin) each night. Respironics REMstar Pro and REMstar Auto have CPAP check mode, which checks the 90% pressure every 30 hours, then decides whether to leave the EPAP unchanged, or changes the EPAP up or down by one but not more than three from set EPAP.23 DeVilbiss’s IntelliPAP AutoAdjust allows setting of amplitude and duration cut-points for apneas and hypopneas to change sensitivity. AutoAdjust does not detect flow limitation and defines central apneas as ,5% of airflow for 10 seconds.21 It continuously scores events, but only decides once per minute whether to adjust pressures. AutoAdjust 2 similarly adjusts pressures once per minute, but also responds to flow limitation based on inspiratory flatness. It uses modulating micro-oscillation during apneas to test for patency and has an algorithm to define periodic breathing, looking for cyclic breathing as short as a 20-second cycle. AutoAdjust 2 holds or lowers pressures in response to central apneas and periodic breathing.

BiLevel/BiPAP

BiPAP provides a higher pressure during inhalation and lower pressure during exhalation. Pressures generally range from EPAP minimum of four to IPAP maximum of 25–30. Most devices use a flow trigger to determine when to change to IPAP. The trigger is set above zero flow to sense a significant patient effort. Different methods including flow, shape, and volume are used to cycle to EPAP in efforts to minimize dyssynchrony. The flow cycle algorithm changes to EPAP when the flow drops below a percentage (eg, 25%) of the peak flow so the patient will not encounter resistance to exhalation.24 Shape cycling algorithm uses shape of flow,25 and volume cycle algorithm uses exhaled volume to cycle to EPAP. There can be significant variation between devices in terms of how quickly pressure levels are met and whether a device has a delay or premature cycle, especially in the setting of leaks.26 If there is a mismatch between the patient’s respiratory cycle and the device control cycle there can be patient discomfort. In older BiPAP devices, the motor was braked at the transition point from higher to lower pressures and the motor was accelerated when the device transitioned from lower to higher pressure, which affected synchrony and tolerability. One method to improve comfort is to allow the blower motor to spin freely on transition between inspiration and expiration. Newer devices allow for a smoother transition in pressure changes, and waveforms can be square, exponential, ramp, or sinusoidal. ResMed has a sharkfin-shaped “Easy-Breathe” waveform.27 The shape of the waveform may be affected by the compliance and resistance of the patient’s respiratory system and the breathing effort, as well as mechanical constraints of blower momentum and propagation delays. In general, BiPAP provides a square wave of PS, but manual or automatic adjustments can give more of a smooth pressure BiPAP provides a higher pressure during inhalation and lower pressure during exhalation. Pressures generally range from EPAP minimum of four to IPAP maximum of 25–30. Most devices use a flow trigger to determine when to change to IPAP. The trigger is set above zero flow to sense a significant patient effort. Different methods including flow, shape, and volume are used to cycle to EPAP in efforts to minimize dyssynchrony. The flow cycle algorithm changes to EPAP when the flow drops below a percentage (eg, 25%) of the peak flow so the patient will not encounter resistance to exhalation.24 Shape cycling algorithm uses shape of flow,25 and volume cycle algorithm uses exhaled volume to cycle to EPAP. There can be significant variation between devices in terms of how quickly pressure levels are met and whether a device has a delay or premature cycle, especially in the setting of leaks.26 If there is a mismatch between the patient’s respiratory cycle and the device control cycle there can be patient discomfort. In older BiPAP devices, the motor was braked at the transition point from higher to lower pressures and the motor was accelerated when the device transitioned from lower to higher pressure, which affected synchrony and tolerability. One method to improve comfort is to allow the blower motor to spin freely on transition between inspiration and expiration. Newer devices allow for a smoother transition in pressure changes, and waveforms can be square, exponential, ramp, or sinusoidal. ResMed has a sharkfin-shaped “Easy-Breathe” waveform.27 The shape of the waveform may be affected by the compliance and resistance of the patient’s respiratory system and the breathing effort, as well as mechanical constraints of blower momentum and propagation delays. In general, BiPAP provides a square wave of PS, but manual or automatic adjustments can give more of a smooth pressure air trapping and reduced tidal volume if expiration time is too short.25 Cycle sensitivity sets the level of inspiratory flow below which the device changes from IPAP to EPAP. High cycle setting is recommended when shortened Ti is needed, such as for COPD or if the patient complains that the breaths are too long. Low cycle is recommended when longer Ti is needed for neuromuscular diseases, weak respiratory effort, or stiff lungs, or if the patient complains that the pressure seems to switch from IPAP to EPAP too quickly. BiPAP can be triggered by spontaneous, timed or spontaneous/timed (ST) modes. In spontaneous mode, inspiration is only triggered when the device senses a flow change. Large leak may cause the trigger to fail if the device does not appropriately adjust. Timed mode triggers at a fixed rate and makes no attempt to synchronize with the patient’s breathing, which can result in breath stacking and patient discomfort. ST mode changes pressures with spontaneous breathing efforts, but if the patient has not triggered a breath by a set respiratory rate, then the device will trigger a breath. ST mode is most often used for primary central apnea or central apneas due to respiratory depression. ST mode may also be used for neuromuscular disease patients, whose respiratory efforts fall during REM sleep, which may make them unable to trigger inspiration.28 Timed mode is often used for patients with severe neuromuscular weakness or spinal cord injury, who are unable to trigger inspiration. BiPAP may worsen central apneas due to CSR by increasing breath size of spontaneous breaths and forcing a triggered breath during the apneic portion, which is when the partial pressure of carbon dioxide (Pco2) level is already at its lowest.29 By further decreasing the Pco2, respiratory drive is reduced further and the duration of the apnea will often lengthen, although the oxygenation may improve with the deeper or forced breath. Sometimes the improved oxygenation and PS will help to eventually stabilize the patient’s breathing,30 but in our experience patients with CSR often find BiPAP intolerable or still have a suboptimal clinical response including fluctuations in the respirations and electroencephalogram.

Auto BiLevel/BiPAP

Like AutoCPAP, not all AutoBiPAP devices work in the same way. Some devices only allow a fixed PS, others set a PS maximum (PSmax), and others allow for both PS minimum (PSmin) and PSmax. Thus AutoBiPAP may not provide adequate ventilator support if PSmin cannot be set. AutoBiPAP devices generally do not have an ST option, so are not recommended for central apneas. ResMed’s VPAP AutoBiPAP and DeVilbiss AutoBiPAP have a fixed set PS. Respironics Series 50 AutoBiPAP fixes PSmin at two and allows setting PSmax, while Series 60 AutoBiPAP allows setting both PSmin and PSmax. Within the limits of PSmin and PSmax, Respironics AutoBiPAP changes EPAP in response to apneas (two apneas or one apnea and one hypopnea) and snoring, and IPAP in response to hypopneas (two hypopneas) and flow limitation, with algorithms similar to REMstar AutoCPAP.31

Adaptive servoventilation (ASV)

Because higher PAP pressures and high PS can induce periodic breathing and CSR, devices have been developed to try to even out the breathing over several breaths. These devices include ResMed VPAP AdaptSV (equivalent to Teijin AutoSet CS) with ASV setting, AirCurve ASV, which has been renamed AirCurve CS PaceWave with ASV and ASVAuto settings, and Respironics BiPAP AutoSV Advanced. Another device, SOMNOvent CR, is available outside of the US from Weinmann (Table 4). ResMed’s standard ASV uses a set fixed EPAP, samples flow 50 times per second, and alters IPAP throughout inspiration to achieve target minute ventilation. The PS range can be 0–20, but default is usually a PSmin of three and PSmax of 15. The device calculates a target minute ventilation based on the recent average weighted minute ventilation, weighted toward the last 3 minutes. ASV uses fuzzy logic to determine the part of the respiratory cycle and whether the current ventilation is below or above the desired target and then adjusts the PS throughout the cycle to achieve that target, thus avoiding abrupt pressure changes. The change in pressure is calculated by multiplying a gain of 0.3 cm H2O/L/min/s by the difference between the target minute ventilation and the actual minute ventilation. An automatic backup rate starts with the current spontaneous rate based on moving average calculated over several breaths and gradually adapts during an apnea to 15 bpm.9 ASVAuto also adjusts the EPAP level similar to the AutoSet algorithm in response to obstructive apneas, flow limitation, and snoring.32 The hope is that by stabilizing breathing, the periodic breathing pattern will subside. If the device is cycling the pressures frequently to maintain the target ventilation, it indicates that the underlying periodic pattern is still present and often the patient will either not tolerate the device or there will be a suboptimal clinical response.33 Respironics BiPAP AutoSV Advanced is set with EPAP minimum and maximum, PSmin and PSmax, max pressure, and auto or fixed rate. Ti, rise time, and Bi-Flex can also be set for comfort. The level of PS is targeted based on instantaneous average inspiratory flow, which is the sum of the inspiratory flows during a time divided by the number of samples during a time in order to adjust for spurious values. The target peak flow is generally set at 90%–95% of the mean peak flow of the last 4 minutes. In an attempt to stabilize breathing in the setting of obstructive features (apnea [,20% flow], hypopnea [20%–60% flow], and snoring), the target peak flow increases from 95% of the mean inspiratory peak flows over the last 4 minutes to the 60th percentile of the inspiratory peak flow values. The target peak flow is also increased to 60th percentile if CSR features are noted based on a CSR index, which measures similarity to a CSR pattern or a flow index that measures fluctuations in breath size.34 The respiratory cycle of AutoSV Advanced is determined by using the average length of the breathing cycle over recent breaths and calculating the expected midpoint of inspiration. Compared to multiple small adjustments in the PS throughout the breath cycle with ResMed’s ASV, the inspiratory PS is determined based on the prior breath’s PS plus a gain based on a moving average of the pressure needed in the prior 30 breaths multiplied by the difference between the target peak inspiratory flow and the current breath’s peak inspiratory flow. An intrabreath PS is given if the actual flow is less than target flow in the 100 ms prior to the expected halfway point of the inspiration of the current breath. If actual flow is larger than target flow, the PS will be decreased for the following breath.34 The EPAP adjustment algorithm of AutoSV Advanced is similar to REMstar Auto algorithm, but uses a triggered breath rather than forced oscillation to differentiate obstructive from open airway events.32 The automatic backup rate of AutoSV Advanced is determined based on a moving window of the last 12 spontaneous breaths. A mandatory breath is given if the breath does not occur within certain parameters, with a minimum breath rate of 8–10 bpm. A fixed backup rate can also be set. The older BiPAP AutoSV did not automatically titrate the expiratory pressure, and the algorithm for the automatic backup rate was not proportional to the baseline breathing rate, but it would give a breath if no spontaneous breath occurred within 8 seconds of end of expected breath length or within 4 seconds, if there was recent triggered breath.35 Respironics BiPAP AutoSV Advanced has been found to be more effective than the older BiPAP AutoSV.35 SV, which targets recent ventilation (ASV) or recent peak flow (AutoSV) is not appropriate for managing patients with respirator insufficiency, for whom BiPAP or VAPS should be considered.

Volume-assured pressure support

Respironics AVAPS (average VAPS) and ResMed iVAPS (intelligent VAPS) adjust the PS in order to maintain target average ventilation over several breaths (Table 5). This mode of PAP is often helpful for patients with respiratory insufficiency due to neuromuscular and restrictive conditions in which respiratory effort varies during sleep or who need PAP during the day, COPD patients with risk of hypoventilation, and for obesity hypoventilation patients who may need compensation based on positional and sleep stage changes. Because many patients have much worse hypoventilation in REM, BiPAP with a fixed PS may provide too much pressure in NREM, which may lead to intolerance or complex sleep apnea and may not provide enough PS in REM to control Pco2 levels. Benefits of VAPS over BiPAP can include maintaining volumes in the setting of altered patient effort based on sleep stage or altered lung mechanics related to position. Lesser PS during wake may increase comfort and aid sleep onset, reduce risk of barotrauma, and lower pressures for most of the time.36 A randomized trial of iVAPS vs BiPAP found that iVAPS delivered a lower mean PS for the oxygenation and transcutaneous Pco2 level and had better adherence than BiPAP.37 Both AVAPS and iVAPS adjust PS and respiratory rate to reach a defined target with the goal of stabilizing the Pco2, which relates directly to alveolar ventilation. With a target tidal volume (eg, AVAPS), if there is a large variance in the respiratory rate, there can be fluctuations in the alveolar ventilation and thus Pco2. By targeting estimated alveolar ventilation (minute ventilation–estimated dead space ventilation; eg, iVAPS), variations in respiratory rate should not affect alveolar ventilation or Pco2 as long as the estimated dead space equals physiologic dead space. The device estimates the anatomic dead space using height.38 However, patients with lung diseases, such as emphysema, have increased physiologic dead space that would be underestimated by the above equation, and thus their alveolar ventilation can be much lower than the estimated alveolar ventilation. Thus, emphysema patients may require high target alveolar ventilation to achieve an adequate actual alveolar ventilation. Alternatively, the “height” can be entered artificially high for emphysema patients, thus the calculated dead space will be closer to physiologic dead space, and therefore iVAPS more closely maintains the actual alveolar ventilation. Respironics AVAPS targets an average tidal volume over several breaths. Typically, the target tidal volume is set based on 6–10 mL/kg ideal body weight. It calculates the average PS provided to the patient over the prior 2 minutes in order to achieve a particular tidal volume. If average recent ventilation is less than target volume, IPAP for the next breath is increased. PS will change at a rate of 2/min if there is unstable breathing and 1/min if there is stable breathing. AVAPS-AE model (and also AVAPS on Trilogy 100 Ventilator) can set maximum rate of pressure change from 1/min to 5/min. AVAPS uses square waveform with Ti and rise time settings. EPAP is fixed with AVAPS, but AVAPS-AE adjusts EPAP similar to Respironics REMstar Auto with a searching protocol between EPAP minimum and maximum. AVAPS either uses a fixed rate or auto backup rate set at 2 bpm lower than the rate of the last six spontaneous breaths.39 ResMed iVAPS uses a similar servoventilator with fuzzy logic for determining respiratory phase as adaptive SV. Unlike adaptive SV, the goal ventilation is set to a target alveolar ventilation, which is defined as minute ventilation minus anatomical dead space ventilation. iVAPS alters the gain every 8/50th second throughout the inspiratory cycle to achieve the target ventilation with a smooth parabolic transition that can be modified with rise time, Ti, and cycle and trigger sensitivities. EPAP is fixed like adaptive SV.40 iVAPS’ intelligent backup rate function uses two-third of the set target patient rate as the backup rate during spontaneous breathing and switches during apneas to the set patient target rate apnea. This reduces potential dyssynchrony during spontaneous breathing, while providing ventilation during apneas at a lower PS than if the backup rate remained lower.41 The iVAPS ventilation and rate targets can be configured using the Learn Target feature. While the patient is awake and comfortably breathing at rest, the clinician initiates the Learn Target session, which typically lasts between 15 minutes and 20 minutes and monitors the breathing while on a base EPAP pressure of 6. It uses the average respiratory rate, and since metabolic rate decreases in sleep, it uses 90% of the average estimated alveolar ventilation of the last 5 minutes of the session to propose a target patient rate and target alveolar ventilation, which can then be set by the clinician.42

Other features of PAP

Humidification, heated tubing, ramp, automatic start and stop functions, alarms, and expiratory pressure relief are device functions that are designed to improve patient comfort and compliance (Table 6). Humidifiers include a water chamber with a heating plate through which the airflow is blown. Increasing the warmth of the heating plate increases humidification. Temperature sensors or humidification sensors allow for regulation of temperature or humidification level. Increasing humidification in the air helps reduce nasal irritation and congestion that can result from the airflow on the nasal passages.43 If the humidified air cools in the tubing, water may condense in the tube or mask, commonly referred to as “rainout”. Insulation sleeves that wrap around the tubing or heated tubing, which includes a heating element in the tubing, can increase humidification and eliminate “rainout”. The controls for the heated tubing are often linked to the warming level of the plate, but some devices allow for dissociation of the controls, which may further help with comfort in some patients. Different amounts of humidification may be needed depending on the external humidity and temperature. For travel, standard PAP devices can be used with external battery packs or with converters to allow them to be powered by a car, boat, or other vehicles. There are also small battery-powered units weighing around 10 oz, such as Z1 CPAP and Z1 Auto from HDM, compared to 48 oz for Respironics System One and 44 oz for ResMed AirSense S10.

Data collection and display

Data from the device can be retrieved on the interface with a data card, cable, and wireless or by cellular and bluetooth to an online platform. Data cards can either be used to download locally or to an online website, which allows for sharing. Summary data from the last month is often viewable on the device. DeVilbiss IntelliPAP devices use codes that represent different data sets that their website uses to generate a report. Data collected varies among devices and can include pressure settings, leak, average, 90%–95% pressures and maximum pressures, PS, tidal volumes, minute ventilation, and apnea hypopnea index. Some devices report more detailed data about respiratory events, which may include central, mixed, obstructive and undetermined apneas, hypopneas, flow limitation, snoring, expiratory puffs, percentage of time in periodic breathing, tidal volume, and minute ventilation. Reports can show summary data over days and months as well as detailed data with the timing of events over the course of one night. Often data can be searched for a 30 day compliance period having over 4 hours of use on 70% of the nights. Respironics System One devices can also show full night waveform tracings with scored events and pressure settings. An oximetry module can be connected to ResMed’s AirSense device to allow for saturation data. More data about adherence tracking systems are available in a review by Schwab et al.44

== Conclusion There are a wide range of PAP devices and a wide range of different algorithms used to provide PAP to treat sleep-disordered breathing. For this reason, devices in the same category may differ greatly in their clinical efficacy and comfort. Understanding how PAP devices function can help the clinician select the best PAP device, appropriately titrate, troubleshoot, and optimize settings for a particular patient. Many comfort features have improved the function and performance of devices, which allows many patients who have been unable to tolerate PAP in the past to become compliant. Many devices track compliance and provide important clinical data to help care for the patients.


Table 1 ResMed’s logic for phase determination

Flow Rate of change Phase
Zero Increasing Start inspiration
Small positive Increasing slowly Early inspiration
Large positive Steady Peak inspiration
Small positive Decreasing slowly Late inspiration
Zero Decreasing fast Start expiration
Small negative Decreasing slowly Early expiration
Large negative Steady Peak expiration
Small negative Increasing slowly Late expiration
Zero Steady Expiratory phase


Table 2 AutoCPAP algorithms

Device ResMed S8/S9/S10 AutoSet ResMed S10 AutoSet for Her Respironics System One REMstar Auto DeVilbiss IntelliPAP AutoAdjust DeVilbiss IntelliPAP AutoAdjust 2
Sampling rate 50 Hz. 50 Hz. 125 Hz. 205 Hz. 250 Hz.
Ventilation measure RMS of the variance of moving average scaled low-pass-filtered absolute value of respiratory flow. RMS of the variance of moving average scaled low-pass-filtered absolute value of respiratory flow. WPF of 20%–80% of inspiratory volume. Scaled amplitude. RMS of filtered flow.
A/H flow comparison Prior 1 min RMS moving average. Prior 1 min RMS moving average. Average of 80th–90th percentile WPFs of prior 4 min moving average. Prior 5 min scaled flow amplitude. 3 min including time before and after event RMS moving average
Apnea detection 2 s RMS (Root Mean Square) moving average <25% for 10 s. 2 s RMS moving average <25% for 10 s. WPF (Weighted peak flow) per breath <20% for 10 s, terminating with breath >30%. Recent 1 min with flow amplitude <10% for 10 s (or set 0%–20% for 6–150 s). 4 s RMS moving average <10% for 10 s.
Non-OA detection S8: None S9–S10: 1 cm 4 Hz FOT throughout apnea with mixed apnea detection. 1 cm 4 Hz FOT with mixed apnea detection. Pressure pulse few seconds into apnea but if larger than expected breath at end of apnea, event is defined as obstructive. <5% for 10 s Modulating 0.07 cm 3.5–4.5 Hz micro-oscillation throughout apnea.
Hypopnea detection S8: 12 s RMS scaled average 25%–50% for 10 s. S9–S10: above with at least 1 obstructed breath. 12 s RMS scaled average 25%–50% for 10 s with at least 1 obstructed breath. 20%–60% for 10 s and ending either with terminating breath over 75% of recent WPF or at 60 s 10%–50% for 10 s (adjustable to 30%–70% for 6–150 s). RMS average 10%–40% default (adjustable to 30%–50%) for 10 s.
Flow limitation detection S8: mid-inspiration flatness S9–S10: breath-by-breath flow limitation index from breath shape index, RMS flatness index, and ventilation change and breath duty cycle. Breath-by-breath flow limitation index from breath shape index, RMS flatness index, and ventilation change and breath duty cycle. 4 breath average of roundness, skewness, and flatness indices and weighted peak inspiratory airflow. NA Flow limitation index based on average of 12 s of breath-by breath-flatness of mid inspiration. Index scored as none, mild, moderate, and severe.
Other events detection S9–S10: unknown apnea – apnea with leak >30 L/min. Undetermined apnea – apnea with leak >30 L/min. 1. Hypoventilation – 5 consecutive breaths with mean ventilation <40% 2. Variable breathing – standard deviation/adjusted mean flow over 4 min window above threshold. Report expiratory puff index number of expiratory puffs per hour. Expiratory puff index based on strings of several breaths scored as none, mild, moderate, and severe.
OA/hypopnea response Increases pressure based on current pressure every 10 s of apnea: increment max 3 when pressure is 4. Increment drops linearly down to 0.5 when pressure is 20. S8: no increase above 10. Increases pressure based on current pressure every 10 s of apnea: increment max 2.5 when pressure is 4. Increment drops linearly down to 0.5 when pressure is 20. If 2 apneas or 1 apnea/1 hypopnea or 2 hypopneas-increases by 1 and holds for 30 s. NRAH logic limits max pressure to 11 or 3 higher than preapnea baseline. If more apneas within 8 min decrease pressure by 2/15 min down to 1 over level that prevents snore then holds pressure for 10 min. Pressure will continue to increase in response to 2 hypopneas. Increases pressure 0.5/min if one event or 1 cm/min if 2 events are present on previous min. Increases pressure 1/min for OA. If event is near end of min, response is delayed until following minute so centered moving window completes to allow event to be scored. Increases pressure 0.5/min if hypopnea with 1 other event in 6 min window or 1/min if hypopnea with >1 events in 6 min window.
Flow limitation response S8: increment max 0.45/breath. Lower increment if high leak or as pressure increases further above 10; S9: uses 3 breath average FL index. Increment typically around 0.6/breath for severely flow limited breaths. Lower increment if lower FL index, high leak or as pressure increases further above 15; S10: increment max 0.6/breath otherwise same as S9. Uses single breath FL index: increment max 0.5/breath for severely flow limited breaths. Lower increment if lower FL index, high leak or as pressure increases further above 10. Pressure increases by 0.5/min in response to FL. Intermittent upward scans by 1.5 over 3 min to see if improvement in FL then deceases if no improvement. If pressure not held by snore, A/H, or VB logic, then enters testing protocol which collects 3–5 min data, then downward search sequence for Pcrit begins ramping down 0.5/min until Pmin as long as no worsening in FL. If worsening, Pcrit is set, and pressure quickly increases by 1.5 and held for 10 min. Then Popt search increases pressure by 0.5/min for at least 2.5 min to test if FL improve, worsen, or stay the same. If improvement, continues 0.5/min pressure increase; if no improvement pressure decreases by 1.5 and sets Popt and holds for 10 min. FL or other events end all holds. NA 0.5/min for moderate–severe flow limitation index as long as there has been an obstructive apnea or hypopnea within the past 8 min. No response if high leak or high expiratory puffs.
Vibratory snore response S8–S9: increment max 1/breath. Lower increment if snore is less severe, high leak or as pressure increases further above 10 S10: increment max 0.6/breath for a loud snore otherwise same as S9. Increment max 0.5/breath. Lower increment if snore is less severe, high leak or as pressure increases further above 10. If 3 snores within 30 s from each other, increase 1 over 15 s then hold for 1 min with higher snore threshold at higher pressures. 1/min for 3 snores per 6 min window. 0.5/min for moderate–severe snore with no response if high leak or expiratory puffs.
Other pressure changes S8: gradual decrease to Pmin over 20 min after apnea or over 10 min after FL or snoring event as soon as breathing is stable. S9–S10: gradual decrease to Pmin over 40 min after apnea, over 20 min after FL or snoring. Gradual decrease to Pmin over 40 min after apnea, over 20 min after snore, and over 60 min after flow limitation as soon as breathing is stable. 1. If high variable breathing is noted, then if recent (5 min) pressure was stable then pressure stays same, if recent pressure decrease then increases by 0.5/min up to 2, and if recent pressure increase then decreases by 0.5/min up to 2. 2. If large leak, reduces pressure by 1 over 10 s and holds pressure for 2 min. Decreases 0.6 every 6 min until either lowest pressure or events occur. If high expiratory puffs, no response for 1–2 min. Decides whether to decrease every min. If no events in 1 min period, small decrease of <0.1/min.

If no events in 6 min period, decrease by 0.1/min. If central apnea, pressure decreases and no increase for 6 min. If periodic breathing, no increase, then pressure decreases if persists.

High leak detection 95th percentile leak >24 L/min. 95th percentile leak >24 L/min Leak level exceeds flow limit for a given pressure 95 L/min. 95 L/min or expected leak for given CPAP level.
Ramp S8–S9: 0–45 min ramp S10: fixed 0–45 min ramp or AutoRamp starts ramping when sleep onset is inferred. 0–45 min ramp or AutoRamp starts ramping when sleep onset is inferred. Smart ramp increases faster if obstructive events or FL occur. 0–45 min ramp. 0–45 min ramp.
Pressure relief Off or 1–3 cm H2O. Off or 1–3 cm H2O. Off or 1–3. Off or 1–3 cm H2O. Off or 1–3 cm H2O.

Note: All pressures in cm ·H2O.

Abbreviations: A/H, apnea/hypopnea; AutoCPAP, auto-adjusting continuous positive airway pressure; CPAP, continuous positive airway pressure; FL, flow limitation; FOT, forced oscillation technique; Hz, hertz; max, maximum; min, minute; NA, not applicable; NRAH, nonresponse apnea hypopnea logic; OA, obstructive apnea; Pcrit, critical pressure; Pmin, minimum pressure; Popt, optimal pressure; RMS, root mean square; s, second; VB, variable breathing; WPF, weighted peak flow.


File:Technology update Treatment of sleep-disordered breathing.pdf




Donate to Apnea Board